Cannabis sativa
Cannabis sativa
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Jazz Pharmaceuticals Ireland Limited. Sativex. Produktresumé. Läkemedelsverket [www]. [updated 2024-10-04, cited 2025-06-30].
FDA. Marinol. FDA [www]. [updated 2004-09-01, cited 2025-06-30].
UK Teratology Information Service (UKTIS). Use of Cannabis in pregnancy. July 2018 Version 2. UKTIS [www]. [cited 2025-06-30].
Reprotox. Cannabis. Micromedex [www]. [cited 2025-06-30].
Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al. Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. PLoS One. 2022;17(11):e0276824.
Delker E, Hayes S, Kelly AE, Jones KL, Chambers C, Bandoli G. Prenatal Exposure to Cannabis and Risk of Major Structural Birth Defects: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023;142(2):269-283.
Duko B, Dachew BA, Pereira G, Alati R. The effect of prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis. Addiction. 2023;118(4):607-619.
Bandoli G, Jelliffe-Pawlowski L, Schumacher B, Baer RJ, Felder JN, Fuchs JD et al. Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757.
Ayonrinde OT, Ayonrinde OA, Van Rooyen D, Tait R, Dunn M, Mehta S et al. Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes. J Dev Orig Health Dis. 2021;12(5):694-703.
Bailey A, Kerr W, Alhay Z, Rom M, Hamilton S, Campbell J et al. Fetal Cannabis Exposure and Neonatal Outcomes: A Systematic Review and Meta-Analysis. Matern Child Health J. 2025;29(5):703-713.
Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol. 2012;34(1):161-7.
DrugBank Onlie. Medical Cannabis: Uses, Interactions, Mechanism of Action. DrugBank [www]. [cited 2025-06-30].
- Jazz Pharmaceuticals Ireland Limited. Sativex. Produktresumé. Läkemedelsverket [www]. [updated 2024-10-04, cited 2025-06-30].
- FDA. Marinol. FDA [www]. [updated 2004-09-01, cited 2025-06-30].
- UK Teratology Information Service (UKTIS). Use of Cannabis in pregnancy. July 2018 Version 2. UKTIS [www]. [cited 2025-06-30].
- Reprotox. Cannabis. Micromedex [www]. [cited 2025-06-30].
- Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al. Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. PLoS One. 2022;17(11):e0276824.
- Delker E, Hayes S, Kelly AE, Jones KL, Chambers C, Bandoli G. Prenatal Exposure to Cannabis and Risk of Major Structural Birth Defects: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023;142(2):269-283.
- Duko B, Dachew BA, Pereira G, Alati R. The effect of prenatal cannabis exposure on offspring preterm birth: a cumulative meta-analysis. Addiction. 2023;118(4):607-619.
- Bandoli G, Jelliffe-Pawlowski L, Schumacher B, Baer RJ, Felder JN, Fuchs JD et al. Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757.
- Ayonrinde OT, Ayonrinde OA, Van Rooyen D, Tait R, Dunn M, Mehta S et al. Association between gestational cannabis exposure and maternal, perinatal, placental, and childhood outcomes. J Dev Orig Health Dis. 2021;12(5):694-703.
- Bailey A, Kerr W, Alhay Z, Rom M, Hamilton S, Campbell J et al. Fetal Cannabis Exposure and Neonatal Outcomes: A Systematic Review and Meta-Analysis. Matern Child Health J. 2025;29(5):703-713.
- Goldschmidt L, Richardson GA, Willford JA, Severtson SG, Day NL. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol. 2012;34(1):161-7.
- DrugBank Onlie. Medical Cannabis: Uses, Interactions, Mechanism of Action. DrugBank [www]. [cited 2025-06-30].